Mycotoxins aren’t living organisms — they’re toxic molecules that trigger antibodies capable of attaching to human tissue and setting off autoimmunity. Understanding that distinction reshapes how we test for and treat mold illness.
Navigating toxin-related illnesses, particularly those involving mold exposure and mycotoxins, can feel overwhelming. However, the availability of evidence-based testing methods provides a clearer path forward. By understanding the range of laboratory assessments, clinicians can make more informed clinical decisions, differentiate between exposure and illness, and develop targeted treatment plans.
Melatonin is widely known for regulating the sleep–wake cycle, but its clinical potential extends far beyond circadian support. Synthesized primarily by the pineal gland, and to a lesser extent in peripheral tissues, melatonin functions as a potent antioxidant, an anti-inflammatory and immunomodulatory agent, a neuroprotective molecule, and an adjunctive anticancer therapy.
